The COBE Spectra cell separator is more effective than the Haemonetics MCS-3P cell separator for peripheral blood progenitor cell harvest after mobilization with cyclophosphamide and filgrastim

被引:15
|
作者
Morton, JAP [1 ]
Baker, DP [1 ]
Hutchins, CJ [1 ]
Durrant, STS [1 ]
机构
[1] ROYAL BRISBANE HOSP,BONE MARROW TRANSPLANT UNIT,HERSTON,QLD 4209,AUSTRALIA
关键词
D O I
10.1046/j.1537-2995.1997.37697335158.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Peripheral blood is rapidly replacing bone marrow as a source of hematopoietic progenitor cells for autologous transplantation. The advantages of peripheral blood progenitor cell transplantation are enhanced by the ability to collect sufficient progenitor cells to ensure rapid neutrophil and platelet recovery in a single procedure on some cell separators. STUDY DESIGN AND METHODS: A prospective randomized study was undertaken to compare peripheral blood progenitor cell yields from two cell separators (MCS-3P, Haemonetics and Spectra, COBE). Fifteen consecutive patients were mobilized with cyclophosphamide 2 g per m(2) (Day 0) and filgrastim 10 mu g per kg (Days 1-11). Consecutive collections (Day 10, Day 11) were performed with each machine once; patients were randomly assigned to either machine for the initial collection. RESULTS: Collection time was longer on the MCS-3P (p = 0.001), and the volume processed was greater with the Spectra (p<0.0001). Despite similar nucleated cell yield (p = 0.62), the yield of CD34(+) cells (p = 0.001) and colony-forming units-granulocytic-monocytic (p = 0.0001) was significantly higher with the Spectra. The yield of nucleated cells per unit of blood volume processed was higher for the MCS-3P (p = 0.0007), while the CD34+ cell yield (p = 1) and colony-forming units-granulocytic-monocytic yield (p = 1) per unit of blood volume processed were similar for the two machines. The collection of CD34+ cells at levels >2 x 10(6) per kg (p = 0.063), 5 x 10(6) per kg (p = 0.031), and colony-forming units-granulocytic-monocytic >1 x 10(6) per kg (p = 0.25) after a single collection was superior for the Spectra. CONCLUSION: The yield of progenitor cells after collection on the Spectra was superior to that achieved with the MCS-3P, because of the larger volume of blood processed per procedure. This would permit more patients to undergo only one collection.
引用
收藏
页码:631 / 633
页数:3
相关论文
共 39 条
  • [31] Early Post-Transplant Outcomes Support Generic Plerixafor Is As Effective as (and in Subgroup More Effective Than) Brand As Adjunct Peripheral Blood Stem-Cell Mobilization Agent for Multiple Myeloma
    Chang, S.
    Yuan, S.
    Kim, H.
    Wang, S.
    TRANSFUSION, 2024, 64 : 75A - 75A
  • [32] Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning
    Worel, N
    Greinix, HT
    Keil, F
    Mitterbauer, M
    Lechner, K
    Fischer, G
    Mayr, W
    Höcker, P
    Kalhs, P
    TRANSFUSION, 2002, 42 (10) : 1293 - 1301
  • [33] 'Late intensification therapy' with or without peripheral blood progenitor cell transplant (PBPCT) in breast cancer larger than 3 cm and with 10 or more positive nodes
    Massidda, B
    Ionta, MT
    Casula, P
    Broccia, G
    BREAST, 1997, 6 (05): : P902 - P902
  • [34] PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) MOBILIZATION AFTER HIGH-DOSE OF CYCLOPHOSPHAMIDE (CTX) PLUS ETOPOSIDE (VP16) AND RHU-GM-CSF (MOLGRAMOSTIM)
    LEGROS, M
    FLEURY, J
    BASILE, M
    CURE, H
    TAVERNIER, F
    CONDAT, P
    CHOLLET, P
    PLAGNE, R
    CHASSAGNE, J
    BLOOD, 1993, 82 (10) : A635 - A635
  • [35] PREDICTIVE FACTORS FOR PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTIONS USING A SINGLE LARGE-VOLUME LEUKAPHERESIS AFTER CYCLOPHOSPHAMIDE AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR MOBILIZATION
    PASSOSCOELHO, JL
    BRAINE, HG
    DAVIS, JM
    HUELSKAMP, AM
    SCHEPERS, KG
    OHLY, K
    CLARKE, B
    WRIGHT, SK
    NOGA, SJ
    DAVIDSON, NE
    KENNEDY, MJ
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (03) : 705 - 714
  • [36] ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin's lymphoma: comparison with high-dose cyclophosphamide plus G-CSF
    Lee, JL
    Kim, S
    Kim, SW
    Kim, EK
    Kim, SB
    Kang, YK
    Lee, J
    Kim, MW
    Park, CJ
    Chi, HS
    Huh, J
    Kim, SH
    Suh, C
    BONE MARROW TRANSPLANTATION, 2005, 35 (05) : 449 - 454
  • [37] ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin's lymphoma: comparison with high-dose cyclophosphamide plus G-CSF
    J-L Lee
    S Kim
    S W Kim
    E-K Kim
    S-B Kim
    Y-K Kang
    J Lee
    M W Kim
    C J Park
    H-S Chi
    J Huh
    S-H Kim
    C Suh
    Bone Marrow Transplantation, 2005, 35 : 449 - 454
  • [38] Peripheral blood progenitor cell mobilization with Dexa-Beam/G-CSF, ether lipid purging, and autologous transplantation after high-dose CBV treatment: A safe and effective regimen in patients with poor risk malignant lymphomas
    Knauf, WU
    Koenigsmann, MP
    Notter, M
    Hoppe, B
    Reufi, B
    Oberberg, D
    Thiel, E
    Berdel, WE
    LEUKEMIA & LYMPHOMA, 1996, 23 (3-4) : 305 - 311
  • [39] THE INFLUENCE OF EXTENSIVE PRIOR CHEMOTHERAPY ON THE MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) USING STEM-CELL FACTOR (RHSCF) AND FILGRASTIM (RMETHUG-SCF) AND ON HEMATOLOGIC RECOVERY POST CYCLOPHOSPHAMIDE, BCNU, AND VP-16 (CBV) IN PATIENTS (PTS) WITH RELAPSED NON-HODGKINS-LYMPHOMA (NHL) - AN INTERIM ANALYSIS
    MOSKOWITZ, C
    STIFF, P
    GORDON, M
    GABRILOVE, J
    BAYER, R
    BROUN, R
    NICHOLS, C
    HO, AD
    WYRES, M
    NIMER, S
    MCNIECE, I
    BLOOD, 1994, 84 (10) : A107 - A107